Biphenyl

Biphenyl

SCHEMBL322601

C=CC=C.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.64
TSHR P16473 1/20 0.47
MAPK1 P28482 2/20 0.45
CYP3A4 P08684 2/20 0.45
TAAR1 Q96RJ0 2/20 0.45
CYP1A2 P05177 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
NOTUM Q6P988 1/20 0.45
MMP3 P08254 1/20 0.45
BCL2L1 Q07817 1/20 0.45
ATM Q13315 1/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41
SLC22A3 O75751 1/20 0.41
SLC6A4 P31645 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27495887 0.97 ALDH1A1 (0.60) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL2932531 0.97 ALDH1A1 (0.60) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL1712848 0.97 ALDH1A1 (0.60) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL19990802 0.94 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL27523826 0.88 ALDH1A1 (0.50) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL27652579 0.87 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL5599687 0.87 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Butadiene SCHEMBL9807163 0.84 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1HSD17B10TDP1
Biphenyl SCHEMBL8536204 0.84 ALDH1A1 (0.53) ALDH1A1TSHRMAPK1CYP3A4TAAR1
Biphenyl SCHEMBL664141 0.83 ALDH1A1 (0.60) ALDH1A1TSHRMAPK1CYP3A4TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116535839-B Resin composition and product thereof 台光电子材料(昆山)股份有限公司 2026-05-19 CN claimed
US-20260132349-A1 DIBLOCK AND TRIBLOCK COPOLYMER CONCENTRATES FOR LUBRICATING OIL COMPOSITIONS INFINEUM INTERNATIONAL LIMITED (US) 2026-05-14 US claimed
WO-2026087378-A1 DIBLOCK AND TRIBLOCK COPOLYMER CONCENTRATES FOR LUBRICATING OIL COMPOSITIONS INFINEUM INTERNATIONAL LIMITED (GB) 2026-04-30 WO claimed
US-20260083659-A1 SUNSCREEN COMPOSITIONS AND METHODS OF USE MARY KAY INC. (US) 2026-03-26 US claimed
CN-120005374-A Resin composition and product thereof 台光电子材料(昆山)股份有限公司 2025-05-16 CN claimed
CN-120005375-A Resin composition and product thereof 台光电子材料(昆山)股份有限公司 2025-05-16 CN claimed
CN-119930892-A Self-toughening hydrocarbon copolymer for high-frequency high-speed copper-clad plate and preparation method thereof 华东理工大学 2025-05-06 CN claimed
CN-119638905-A Low-loss resin composition, prepreg and copper-clad laminate 江门伊帕思新材料科技有限公司 2025-03-18 CN claimed
CN-119161532-A High-temperature-resistant salt-resistant cross-linked hydrophobic polymer and preparation method and application thereof 中国石油化工股份有限公司 2024-12-20 CN claimed
CN-118546278-A Hyperbranched polyvinyl polymer and preparation method and application thereof 安徽理工大学 2024-08-27 CN claimed
CN-1183728-A Absorbent foams made from high internal phase emulsions for absorbing aqueous fluids PROCTER & GAMBLE (US) 1998-06-03 CN claimed
CN-1177966-A Absorbent foams made from high internal phase emulsiona useful for acquiring and distributing aqueous fluids PROCTER & GAMBLE (US) 1998-04-01 CN claimed
CN-1177359-A Foams made form high internal phase emulsions useful as absorbent members for catamenial pads PROCTER & GAMBLE (US) 1998-03-25 CN claimed
CN-1175959-A Foam material for absorbing aqueous fluids made from high internal phase emulsions having very high water to oil ratios PROCTER & GAMBLE (US) 1998-03-11 CN claimed
CN-1175911-A Recycling of prepared high internal phase emulsions in a continuous process PROCTER & GAMBLE (US) 1998-03-11 CN claimed
EP-0242618-B1 Transparent optical article and process for preparing same NIPPON OILS & FATS CO LTD (JP) 1994-11-02 EP claimed
US-4948854-A COPOLYMER INCLUDING ITACONIC ACID DIESTER SEIKO EPSON CORPORATION (JP) 1990-08-14 US claimed
EP-0242618-A2 Transparent optical article and process for preparing same NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1987-10-28 EP claimed
EP-0011509-B1 OLEFIN POLYMERISATION CATALYST COMPONENT AND POLYMERISATION PROCESS EMPLOYING IT ENICHEM ELASTOMERS LIMITED (GB) 1982-12-22 EP claimed
EP-0011509-A1 Olefin polymerisation catalyst component and polymerisation process employing it ENICHEM ELASTOMERS LIMITED (GB) 1980-05-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132349-A1 DIBLOCK AND TRIBLOCK COPOLYMER CONCENTRATES FOR LUBRICATING OIL COMPOSITIONS F12, CFD, FANCD2 ALDH1A1 3778/4885TSHR 890/4885MAPK1 2914/4885
US-20260083659-A1 SUNSCREEN COMPOSITIONS AND METHODS OF USE CUTA, TYR, SUN2 ALDH1A1 327/4885TSHR 2955/4885MAPK1 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.